Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)
0.8050
-0.0100 (-1.23%)
Aug 27, 2026, 11:59 AM HKT
HKG:0460 Revenue
Sihuan Pharmaceutical Holdings Group had revenue of 1.47B CNY in the half year ending December 31, 2025, with 82.87% growth. This brings the company's revenue in the last twelve months to 2.63B, up 25.52% year-over-year. In the year 2025, Sihuan Pharmaceutical Holdings Group had annual revenue of 2.62B with 37.71% growth.
Revenue (ttm)
2.63B CNY
Revenue Growth
+25.52%
P/S Ratio
2.42
Revenue / Employee
926.14K CNY
Employees
2,843
Market Cap
7.35B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.62B | 716.90M | 37.71% |
| Dec 31, 2024 | 1.90B | 40.57M | 2.18% |
| Dec 31, 2023 | 1.86B | -320.65M | -14.70% |
| Dec 31, 2022 | 2.18B | -857.20M | -28.21% |
| Dec 31, 2021 | 3.04B | 574.17M | 23.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
Revenue RankingsSihuan Pharmaceutical Holdings Group News
- 3 years ago - Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, Its Innovative Drug Anaprozole Sodium Enteric-coated Tablets Obtains Drug Registration Approval From NMPA - PRNewsWire